November 16, 2012
Napoleone Ferrara, MD, PhD, the molecular biologist credited with helping decipher how tumors grow, and with development of new treatments for both cancer and age-related macular degeneration, has been named recipient of The Economist magazine’s 2012 Innovation Award for bioscience.
August 28, 2015
Four University of California, San Diego School of Medicine researchers have been selected to receive the newly established National Cancer Institute (NCI) Outstanding Investigator Award. The multi-million dollar awards fund new projects that have an unusual potential in cancer research over seven years.
May 29, 2020
A $1 million gift from the John and Mary Tu Foundation is helping to increase the number of people tested for COVID-19, as well as develop new ways to track and treat the virus.
July 25, 2024
An experimental cancer drug could ease cognition for individuals with Rett syndrome, a rare disorder linked to autism, according to new research from the Muotri Lab at the University of California San Diego — a discovery that could lead to therapies for patients with other neurologic conditions.
August 19, 2024
A team of researchers from UC San Diego has developed the first multiscale computational model to simulate the therapeutic mechanisms of a drug candidate for heart failure from the atomic level to the organ system scale.
May 4, 2020
The Altman Clinical and Translational Research Institute at University of California San Diego has received a five-year, $54.7 million Clinical and Translational Science Award from the National Center for Advancing Translational Science (NCATS), part of the National Institutes of Health.
September 23, 2022
The University of California San Diego announces establishing a new oneAPI Center of Excellence at its San Diego Supercomputer Center. The oneAPI Center will focus on enabling high-performance molecular dynamics simulations in Amber—a biomolecular simulations software package used by thousands.
December 6, 2011
…50’ in Research and Discovery Photos by Erik Jepsen/UC San Diego Publications As the campus looks beyond last year’s 50th anniversary celebrations, university leaders are developing a new long-term vision for the decades ahead. The central idea behind that vision is a familiar one: “We will build on faculty collaboration…
April 13, 2017
…metabolic models, to optimize CHO cell production of biologic drugs in the hope of driving down their costs.
April 13, 2017
…lines to accelerate biologic drug development is a goal of the CHO Systems Biology Center at the University of California San Diego Jacobs School of Engineering. Center researchers are developing new technologies and training the next generation of cell line engineers and systems biology specialists to advance CHO cell engineering…
